Symbol="ANAB"
AssetType="Common Stock"
Name="AnaptysBio Inc"
Description="AnaptysBio, Inc., a clinical-stage biotechnology company, is dedicated to developing therapeutic product candidates for inflammation and immuno-oncology indications. The company is headquartered in San Diego, California."
CIK="1370053"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="10421 PACIFIC CENTER COURT, SUITE 200, SAN DIEGO, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="501836000"
EBITDA="-130327000"
PERatio="None"
PEGRatio="0"
BookValue="7.07"
DividendPerShare="0"
DividendYield="0"
EPS="-4.92"
RevenuePerShareTTM="0.379"
ProfitMargin="0"
OperatingMarginTTM="-12.25"
ReturnOnAssetsTTM="-0.139"
ReturnOnEquityTTM="-0.524"
RevenueTTM="10691000"
GrossProfitTTM="-78511000"
DilutedEPSTTM="-4.92"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0.416"
AnalystTargetPrice="32.5"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="178.16"
PriceToBookRatio="3.005"
EVToRevenue="91.55"
EVToEBITDA="-3.592"
Beta="-0.135"
num_52WeekHigh="32.44"
num_52WeekLow="17.96"
num_50DayMovingAverage="19.41"
num_200DayMovingAverage="23.98"
SharesOutstanding="26487200"
DividendDate="None"
ExDividendDate="None"
symbol="ANAB"
open="18.72"
high="18.89"
low="17.96"
price="18.12"
volume="181649.00"
latest_trading_day="2023-07-21"
previous_close="18.59"
change="-0.47"
change_percent="-2.5282%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="100"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="0"
Volume_recent_avg="207754"
Change_recent_avg="-0.06"
Delta_recent_avg="0.95"
Variance_recent_avg="0.47"
Change_ratio_recent_avg="-0.35"
RSI_change="FALSE"
ADX_change="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="0"
Aroon_momentum_negative="100"
image_negative_thumbnail_id_1="1139"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0172.jpeg"
image_negative_thumbnail_id_2="167"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0009.jpeg"
image_neutral_thumbnail_id_1="562"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0037.jpeg"
image_neutral_thumbnail_id_2="536"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0063.jpeg"
image_positive_thumbnail_id_1="643"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0065.jpeg"
image_positive_thumbnail_id_2="696"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0012.jpeg"
image_professor_thumbnail_id_1="1201"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0035.jpeg"
image_professor_thumbnail_id_2="1173"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0007.jpeg"
